STAT

Trump proposes importing medicines, but he’s really seeking a quick political hit

The new White House plan to import medicines from Canada is being billed as historic, but you better gas up if you think the proposal will save you from making a trip across the border to buy insulin.

Along with some other medicines known as biologics, which are typically administered by physicians, the diabetes treatment will not be part of the new proposal announced on Wednesday. Neither will many cancer medicines. And this is just one of several limitations to a plan that, in all fairness, holds some potential, but appears politically motivated more than anything else.

This is among the reasons I think the plan will have, at best, a modest impact. But before I delve into the nitty-gritty, let’s look at the politics.

Timing, of course, is everything and when it comes to prescription drugs, President Trump needs

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related Books & Audiobooks